Status:
UNKNOWN
Intravenous Infusion of Lidocaine in Gastroscopy
Lead Sponsor:
Shandong University
Conditions:
Sedation
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Intravenous infusion of lidocaine significantly reduces incidence of bucking when perfomed gastroscopy.
Detailed Description
This study divide patients into two groups, the patients in lidocaine group will be given lidocaine; the control group will be given placebo .the primary endopiont was to investigate whether intraveno...
Eligibility Criteria
Inclusion
- patients aged \>18 years who were scheduled for ERCP at Qilu hospital.
Exclusion
- patients with ASA (American Society of Anesthesiologists) Class 4 or 5, pre-existing hypoxemia (SpO2 \<90%), hypotension (systolic blood pressure \<90 mm Hg), bradycardia (HR\<50 beats/min), uncontrolled hypertension (SBP \>170 mm Hg, diastolic blood pressure\>100 mm Hg), severe renal or liver failure, pregnancy or lactation, allergy to lidocaine, atrioventricular block, epilepsy, and inability to give informed consen
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04439773
Start Date
July 1 2020
End Date
December 31 2020
Last Update
June 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012